Advertisement
Canada markets close in 1 hour 44 minutes

  • S&P/TSX

    21,620.79
    -35.26 (-0.16%)
     

  • S&P 500

    5,013.46
    -8.75 (-0.17%)
     

  • DOW

    37,760.27
    +6.96 (+0.02%)
     

  • CAD/USD

    0.7260
    -0.0004 (-0.05%)
     

  • CRUDE OIL

    82.81
    +0.12 (+0.15%)
     

  • Bitcoin CAD

    86,057.42
    +1,089.10 (+1.28%)
     

  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     

  • GOLD FUTURES

    2,397.60
    +9.20 (+0.39%)
     

  • RUSSELL 2000

    1,949.27
    +1.33 (+0.07%)
     

  • 10-Yr Bond

    4.6430
    +0.0580 (+1.26%)
     

  • NASDAQ

    15,626.05
    -57.32 (-0.37%)
     

  • VOLATILITY

    18.08
    -0.13 (-0.72%)
     

  • FTSE

    7,877.05
    +29.06 (+0.37%)
     

  • NIKKEI 225

    38,079.70
    +117.90 (+0.31%)
     

  • CAD/EUR

    0.6815
    +0.0013 (+0.19%)
     
MARKETS LIVE BLOG:

STOCKS RISE AS TECHS REVIVE, WITH NETFLIX EARNINGS ON TAP

Tesla shares slide to 52-week low; stock is down roughly 40% year-to-date

TCDA ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of March 8, 2021 in the Class Action Filed on Behalf of Tricida, Inc. Limited Shareholders

Newsfile Corp.
·1 min read

New York, New York--(Newsfile Corp. - March 5, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Tricida, Inc. (NASDAQ: TCDA) alleging that the Company violated federal securities laws.

Class Period: September 4, 2019 and October 28, 2020
Lead Plaintiff Deadline: March 8, 2021

Learn more about your recoverable losses in TCDA:
http://www.kleinstocklaw.com/pslra-1/tricida-inc-loss-submission-form?id=13368&from=5

The filed complaint alleges that Tricida, Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) Tricida's NDA for veverimer was materially deficient; (ii) accordingly, it was foreseeably likely that the FDA would not accept the NDA for veverimer; and (iii) as a result, the Company's public statements were materially false and misleading at all relevant times.

ADVERTISEMENT

Shareholders have until March 8, 2021 to petition the court for lead plaintiff status. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

For additional information about the TCDA lawsuit, please contact J. Klein, Esq. by telephone at 212-616-4899 or click the link above.

J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
J. Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
jk@kleinstocklaw.com
Telephone: (212) 616-4899
Fax: (347) 558-9665
www.kleinstocklaw.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/76220